Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Leukemia, Myeloid, Acute 6Warts 2Sepsis 1Prostatic Neoplasms 1Neoplasms 1Myelodysplastic Syndromes 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Biphenotypic, Acute 1

Interventions

Cryotherapy 12resiquimod 6Cantharidin 5PRA1 protein, Candida albicans 4Tuberculin 3Salicylic Acid 3Cholecalciferol 3plerixafor 2VP-102 2Solutions 2Sodium Chloride 2Saline Solution 2Photochemotherapy 2Percutaneous Collagen Induction 2N-phenylacetoaminomethylene-DL-p-nitrophenylalanine 2Measles-Mumps-Rubella Vaccine 2Lasers 2Hydrogen Peroxide 2Human Papillomavirus Recombinant Vaccine nonavalent 23-ingenyl angelate 22-Propanol 2methyl 5-aminolevulinate 1leupin 1lactic acid, salicylic acid drug combination 1human papillomavirus vaccine, L1 type 16, 18 1green tea extract polyphenone E 1gluconic acid 1ethyl pyruvate 1compound W 1ammonium trichloro(dioxoethylene-O,O'-)tellurate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Warts × 2-Propanol × Clear all
NCT03691831 2020-10-27

A Study of A-101 Topical Solution for the Treatment of Common Warts

Aclaris Therapeutics, Inc.

Phase 3 Completed
502 enrolled 22 charts

Warts

NCT03687372 2020-10-05

Study of A-101 Topical Solution for the Treatment of Common Warts

Aclaris Therapeutics, Inc.

Phase 3 Completed
503 enrolled 22 charts

Warts

Data powered by HemOnc (CC BY 4.0) Colophon âš¡